Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1986-2-28
|
pubmed:abstractText |
The usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci and its implications for therapy were examined. Hospital records were reviewed for 59 patients from each of whom more than one isolate of coagulase-negative staphylococci was obtained. In patients with a prosthetic device, 81% of 59 infectious episodes were due to a slime-positive coagulase-negative staphylococci. In contrast, 22 noninfectious episodes (in which the organisms were contaminants) were equally distributed between episodes due to slime-positive or slime-negative isolates (P = .005). Only 32% of infections caused by slime-positive organisms, in contrast to 100% of infections caused by slime-negative organisms, were improved by treatment with antibiotics alone (P = .02). Prosthetic device removal in addition to antibiotic treatment significantly improved the outcome in patients with infections due to slime-positive organisms when compared with treatment with antibiotics alone (93% vs. 32% improvement; P = .00025).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
332-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2935582-Anti-Bacterial Agents,
pubmed-meshheading:2935582-Coagulase,
pubmed-meshheading:2935582-Glycosaminoglycans,
pubmed-meshheading:2935582-Humans,
pubmed-meshheading:2935582-Polysaccharides, Bacterial,
pubmed-meshheading:2935582-Prostheses and Implants,
pubmed-meshheading:2935582-Staphylococcal Infections,
pubmed-meshheading:2935582-Staphylococcus
|
pubmed:year |
1986
|
pubmed:articleTitle |
Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|